{"protocolSection":{"identificationModule":{"nctId":"NCT06478602","orgStudyIdInfo":{"id":"No: 3505/15.02.2023"},"organization":{"fullName":"Academic Emergency County Hospital Sibiu","class":"OTHER"},"briefTitle":"Implications of Faecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis","officialTitle":"Implications of Faecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-02-15","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-03-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2026-03-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-23","studyFirstSubmitQcDate":"2024-06-23","studyFirstPostDateStruct":{"date":"2024-06-27","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-06-23","lastUpdatePostDateStruct":{"date":"2024-06-27","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR_INVESTIGATOR","investigatorFullName":"Cristian Ichim","investigatorTitle":"Resident Doctor, Ph.D. student","investigatorAffiliation":"Academic Emergency County Hospital Sibiu"},"leadSponsor":{"name":"Cristian Ichim","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The study aims to investigate the beneficial effects of fecal transplantation in patients diagnosed with liver cirrhosis (regardless of etiology)."},"conditionsModule":{"conditions":["Liver Cirrhosis"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":30,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Fecal Microbiota Transplantation (FMT) in Patients with Liver Cirrhosis","type":"EXPERIMENTAL","description":"The experimantal group will receive fecal transplantation from a healthy donor. The study results will be obtained by interpreting the evolution of imaging and laboratory analyses (blood and fecal matter) as well as the patients clinical condition - compared to the initial phase and the control group. Patients will undergo fecal transplantation using a minimum of 70 grams of material collected and tested from a healthy donor. The fecal matter will be transplanted into the cecum using a colonoscope","interventionNames":["Biological: Fecal Microbiota Transplantation"]},{"label":"Control","type":"NO_INTERVENTION","description":"The control group will consist of patients who will be monitored for their progress on standard treatment."}],"interventions":[{"type":"BIOLOGICAL","name":"Fecal Microbiota Transplantation","description":"Performing a colonoscopy with fecal microbiota transplantation at the level of the cecum.","armGroupLabels":["Fecal Microbiota Transplantation (FMT) in Patients with Liver Cirrhosis"],"otherNames":["Colonoscopy"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Implications of Faecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis","description":"The transfer of microbiota could potentially influence hepatic fibrosis via the gut-liver axis, as well as other complications generated by cirrhosis such as encephalopathy, ascites etc.","timeFrame":"Up to 3 months"},{"measure":"Implications of Fecal Microbiota Transplantation in Modulating the Condition of Other Organs","description":"The transfer of microbiota could potentially influence the function of other major organs of the body.","timeFrame":"Up to 3 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of liver cirrhosis according to current protocols.\n* Adult patients, conscious, cooperative.\n\nExclusion Criteria:\n\n* Patients with hemodynamic and/or respiratory instability.\n* Patients with contraindications for colonoscopy or fecal transplantation.\n* Patients with acute or chronic infections with HIV, Tuberculosis, MDR Enterobacteria, CMV, parasites, fungi.\n* Associated oncological pathology.\n* Patients with other causes of severe immunodeficiencies.\n* Lack of compliance with the conditions imposed by the research project.\n* Patients who do not sign the informed consent.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Cristian Ichim, Resident","role":"CONTACT","phone":"0040751138598","email":"cristian.ichim@ulbsibiu.ro"}],"overallOfficials":[{"name":"Victoria Birlutiu, Prof. Dr.","affiliation":"County Clinical Emergency Hospital of Sibiu","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"County Clinical Emergency Hospital of Sibiu","status":"RECRUITING","city":"Sibiu","zip":"550245","country":"Romania","contacts":[{"name":"Cristian Ichim, Resident","role":"CONTACT","phone":"0040751138598","email":"cristian.ichim@ulbsibiu.ro"},{"name":"Victoria Birlutiu, Prof. Dr.","role":"SUB_INVESTIGATOR"}],"geoPoint":{"lat":45.8,"lon":24.15}}]},"referencesModule":{"references":[{"pmid":"38001930","type":"BACKGROUND","citation":"Boicean A, Birlutiu V, Ichim C, Brusnic O, Onisor DM. Fecal Microbiota Transplantation in Liver Cirrhosis. Biomedicines. 2023 Oct 30;11(11):2930. doi: 10.3390/biomedicines11112930."},{"pmid":"38732276","type":"BACKGROUND","citation":"Boicean A, Ichim C, Todor SB, Anderco P, Popa ML. The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders. Diagnostics (Basel). 2024 Apr 23;14(9):861. doi: 10.3390/diagnostics14090861."}]},"ipdSharingStatementModule":{"ipdSharing":"NO","description":"The study results will be made public and other researchers will be able to receive the anonymized database upon reasonable request."}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000008103","term":"Liver Cirrhosis"},{"id":"D000005355","term":"Fibrosis"}],"ancestors":[{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000008107","term":"Liver Diseases"},{"id":"D000004066","term":"Digestive System Diseases"}],"browseLeaves":[{"id":"M11103","name":"Liver Cirrhosis","asFound":"Liver Cirrhosis","relevance":"HIGH"},{"id":"M8485","name":"Fibrosis","asFound":"Cirrhosis","relevance":"HIGH"},{"id":"M11107","name":"Liver Diseases","relevance":"LOW"},{"id":"M8883","name":"Gastrointestinal Diseases","relevance":"LOW"},{"id":"M7255","name":"Digestive System Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC06","name":"Digestive System Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"All","name":"All Conditions"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M11110","name":"Liver Extracts","relevance":"LOW"}],"browseBranches":[{"abbrev":"Hemat","name":"Hematinics"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}